Quick Answer
SeaStar Medical Holding Corp reported Net Income Loss of -$12.15 million for the year ending 2025.
- SeaStar Medical Holding Corp showed an increase of +51.1% in Net Income Loss from 2024 to 2025.
- This data is from SeaStar Medical Holding Corp's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $1.71 million | Q2 2021: -$1.98 million | Q3 2021: $236.0 thousand | Q1 2022: -$1.00 million | Q2 2022: -$902.0 thousand | Q3 2022: -$1.89 million | Q1 2023: -$7.10 million | Q2 2023: -$2.45 million | Q3 2023: -$7.23 million | Q1 2024: -$12.70 million | Q2 2024: -$3.24 million | Q3 2024: -$4.48 million | Q1 2025: -$3.77 million | Q2 2025: -$2.00 million | Q3 2025: -$3.47 million.
- Over the full 5 years of available data (2021 to 2025), SeaStar Medical Holding Corp's Net Income Loss has declined by 164.4%.
- Historical annual values: Fiscal year 2025: -$12.15 million | Fiscal year 2024: -$24.83 million | Fiscal year 2023: -$26.23 million | Fiscal year 2022: -$12.19 million | Fiscal year 2021: -$4.60 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: